A personalized vaccine may help keep melanoma from returning after surgery. Sutter Health investigators in San Francisco helped lead a phase 2 study behind the advance.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
Personalized vaccine targets melanoma recurrence

Melanoma Cancer type
Phase 2 Study phase
KEYNOTE-942 Study name